Index Detail:Thomson Reuters Equity China Index
CHICAGO May 30 - A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer.
- Airbus sees "several hundred" orders at Paris Airshow
- UPDATE 2-Magnitude 8.5 quake strikes off eastern Japan, no tsunami danger or damage reports
- UPDATE 1-Magnitude 8.5 quake strikes off eastern Japan, no tsunami danger or immediate damage
- Magnitude 8.5 quake strikes off eastern Japan, no immediate reports of damage
|100 OZ GOLD MAR4||$1,190.30||$1.30|